Secured Research | Equipment Finance Originator | Monitor | Monitor Suite | Converge | STRIPES Leadership
No Result
View All Result
ABF Journal
Forward for Specialty Finance
SUBSCRIBE
Lender & Services Directory
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Recruiting
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Events
  • Advertise
  • Contact Us
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Recruiting
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Events
  • Advertise
  • Contact Us
No Result
View All Result
ABF Journal
No Result
View All Result
Home Deal Announcements

H.I.G. Capital Completes Recapitalization of Navitas Life Sciences

byIan Koplin
September 14, 2022
in Deal Announcements

H.I.G. Capital, a global alternative investment firm with more than $50 billion of equity capital under management, is pleased to announce that one of its affiliates has completed the recapitalization of Navitas Life Sciences.

Headquartered in Princeton, NJ, Navitas is a global technology-enabled clinical research organization (CRO) providing outsourced data science (including biostatistics, statistical programming and data management), regulatory and safety services (including software and monitoring) and other full-service CRO capabilities to blue-chip large and mid-sized pharmaceutical and government clients. The company’s functional service expertise optimizes the clinical trial process, drives cost efficiencies for its clients and ensures adherence to regulatory compliance requirements. The company’s global operations span the United States, India, Europe and South America.

“We are delighted to partner with H.I.G. in our mission to accelerate global access to outstanding drug development outcomes by harnessing the power of technology and domain knowledge,” Srinivasan HR, CEO at Navitas, said. “H.I.G., with its global network and diverse experience across healthcare and life sciences, is an ideal partner to support Navitas’ continued growth as a global next generation CRO. We are excited to leverage H.I.G.’s capital and resources to accelerate our own growth initiatives while continuing to deliver outstanding service to our clients.”

“Navitas’ capabilities go well beyond a traditional CRO as the Company leverages its expertise and technology for innovation and growth,” Camilo E. Horvilleur, managing director at H.I.G. Capital, said. “As technology becomes an integral part of drug development value chain, we expect Navitas to become an increasingly important strategic partner to life sciences companies.”

Previous Post

National Business Capital Secures $11MM to Support Sneaker Retailer’s Growth

Next Post

Small Business Loan Approval Rates Dip at Big Banks in August, Improve for Smaller Banks

Related Posts

Deal Announcements

Atea Pharmaceuticals Secures Credit Facility for Up to $200MM from Hercules Capital

November 10, 2026
Deal Announcements

Yoco Secures $100MM Facility from Victory Park Capital

November 10, 2026
Deal Announcements

Codexis Refinances Debt with $60MM Trinity Capital Term Loan

November 10, 2026
Advanced Power Closes $100M Corporate Credit Facility
News

JPalmer Collective Closes $7MM Line of Credit for Gems One

November 10, 2026
Deal Announcements

Wingspire Capital Provides Revolver to Media, Music and Fashion Company

November 10, 2026
Deal Announcements

Monroe Capital Supports InTandem Capital Partners’ Investment in Atlas Health

November 10, 2026
Next Post

Small Business Loan Approval Rates Dip at Big Banks in August, Improve for Smaller Banks

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Middle Market Debt Weekly – March 31, 2025

Sponsors Turn Debt Into Distributions: How Leveraged Loan Recaps Became Private Equity’s Exit Substitute

October 23, 2026

Ballots and Balance Sheets: What the Midterms Mean for Deal Flow and Asset-Based Lenders

October 30, 2026

Higher Rates, Steady Fundamentals: BMO’s Jon Biorkman on ABL in the Middle Market

October 23, 2026

Collateral First, Hype Second: Mike Semanco on Lending Through the AI Boom

October 16, 2026

About Us

For over 50 years, RAM Holdings’ brands have led the commercial finance industry in publishing, talent development, research and events. ABF Journal’s audience is comprised of as many as 18,000 specialty finance industry executives, private equity investors, investment bankers, advisors, service providers and more.

Our Brands

  • Secured Research
  • Equipment Finance Originator
  • Monitor
  • Monitor Suite
  • Converge
  • STRIPES Leadership

 

Learn More

  • Advertise
  • Magazine
  • Contact Us

Newsletter

Driving specialty finance forward for decades with insights, recognition and deals. Sign up now.

SUBSCRIBE >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • News
    • People
    • Economy
    • All News
  • Deals
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Magazine
    • Magazine Issues
    • Nominations
  • Molloy Associates
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Events
  • Advertise
  • Contact Us
Provider Directory >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years